Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry.
Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry with Grant Playter, associate editor. Topics of discussion include Deloitte’s recent report on the state of biopharma, broader digitalization trends, how generative AI will affect pharma going forward, the push toward supply chain resilience, and more.
[insert text]